J. Clin. Lab. Anal. volume 29, issue 6, P444-450 2014 DOI: 10.1002/jcla.21792 View full text
|
|
Share
Dong Wook Jekarl, Yonggoo Kim, Jihyang Lim, Myungshin Kim, Kyungja Han, Bin Cho, Hak-Ki Kim, Woo-Sung Min, Chang-Ki Min

Abstract: As evidenced by the data, FRC might be a favorable prognostic marker for TA-TMA, but additional studies with larger patients groups are required for validation of clinical applications.